Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Monoamine oxidase inhibitors.

S Lippmann

    American Family Physician
    |July 1, 1986
    PubMed
    Summary

    Monoamine oxidase inhibitors (MAOIs) provide effective treatment for depression and anxiety, including atypical depression. While requiring careful monitoring, their risks are lower than previously believed, with hypotension being the primary side effect.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Fabrication of shallow EUV gratings on silicon by irradiation with helium ions.

    Nanotechnology·2025
    Same author

    Countering antimicrobial resistance.

    Pulmonology·2025
    Same author

    Electric pulse heating device for the analysis of solid/solid phase transformations.

    The Review of scientific instruments·2021
    Same author

    Results of 115 Rubis II reverse thumb carpometacarpal joint prostheses with a mean follow-up of 10 years.

    The Journal of hand surgery, European volume·2017
    Same author

    [Recruitment for general practice - relationship between practice-based curriculum and career choice].

    Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))·2013
    Same author

    Insomnia: therapeutic approach.

    Southern medical journal·2001

    Area of Science:

    • Pharmacology
    • Psychiatry
    • Neuroscience

    Background:

    • Monoamine oxidase inhibitors (MAOIs) are established antidepressants.
    • Atypical depression presents unique challenges in treatment selection.
    • Previous perceptions of MAOI risks may have limited their clinical application.

    Purpose of the Study:

    • To highlight the expanded therapeutic potential of MAOIs.
    • To address and clarify the risks associated with MAOI use.
    • To emphasize the importance of physician awareness and patient education.

    Main Methods:

    • Review of clinical data and pharmacological profiles of MAOIs.
    • Analysis of side effect profiles, focusing on hypotension and hypertensive reactions.
    • Identification of contraindications and drug/food interactions.

    Main Results:

    • MAOIs offer effective treatment for a broader spectrum of depressed and anxious patients, especially those with atypical depression.
    • Hypotension is identified as the principal side effect.
    • Hypertensive reactions are preventable through strict avoidance of sympathomimetic substances.

    Conclusions:

    • MAOIs represent valuable therapeutic options for specific patient populations.
    • The risks associated with MAOIs are manageable with appropriate clinical vigilance and patient guidance.
    • Careful patient selection and education are crucial for safe and effective MAOI therapy.

    Related Experiment Videos